Cargando…
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
Autores principales: | Xia, Shuai, Zhu, Yun, Liu, Meiqin, Lan, Qiaoshuai, Xu, Wei, Wu, Yanling, Ying, Tianlei, Liu, Shuwen, Shi, Zhengli, Jiang, Shibo, Lu, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075278/ https://www.ncbi.nlm.nih.gov/pubmed/32047258 http://dx.doi.org/10.1038/s41423-020-0374-2 |
Ejemplares similares
-
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
por: Xia, Shuai, et al.
Publicado: (2020) -
Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4
por: Xia, Shuai, et al.
Publicado: (2019) -
Peptide-Based Membrane Fusion Inhibitors Targeting HCoV-229E Spike Protein HR1 and HR2 Domains
por: Xia, Shuai, et al.
Publicado: (2018) -
A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
por: Xia, Shuai, et al.
Publicado: (2019) -
Inefficiency of Sera from Mice Treated with Pseudotyped SARS-CoV to Neutralize 2019-nCoV Infection
por: Liu, Zezhong, et al.
Publicado: (2020)